Effect of solvent on retarding the release of diltiazem HCl from Polyox-based liquisolid tablets

Waseem Kaialy, Hussaini Bello, Kofi Asare-Addo, Ali Nokhodchi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objectives: The aim of this work was to investigate the use of liquisolid technique to sustain the release of a model highly soluble drug, diltiazem HCl, from liquisolid matrices containing Polyox, a recently proposed matrix-forming hydrophilic polymer as an alternative to hypromellose. Methods: Polyox-based liquisolid formulations prepared using several non-volatile solvents (i.e. polysorbate 80, polyethylene glycol, polyethylene glycol 200 and polyethylene glycol 600) and then characterised using differential scanning calorimetry and powder X-ray diffraction. The influence of solvent on retarding the release of diltiazem HCl from Polyox-based liquisolid tablets compared to conventional physical mixture tablets was studied. Key findings: Liquisolid tablets exhibited greater retarding properties compared to conventional tablets. The use of polysorbate produced a slower release pattern of the drug from diltiazem hydrochloride (DTZ) liquisolid tablets compared to propylene glycol and polyethylene glycol (200 and 600). The release retardation was decreased with the increase in the concentration of the drug within drug:solvent liquid medication used. Solid-state analysis suggested the presence of a fraction of the drug mass in a solubilised state within polysorbate in liquisolid powders. Conclusion: Polyox-based matrix tablets prepared using liquisolid technique in the presence of a carefully selected non-volatile solvent could produce desirable, more sustained release profiles of highly water-soluble drugs compared to conventional physical mixture tablets.

LanguageEnglish
Pages1396-1402
Number of pages7
JournalJournal of Pharmacy and Pharmacology
Volume68
Issue number11
Early online date7 Oct 2016
DOIs
Publication statusPublished - Nov 2016

Fingerprint

Diltiazem
Tablets
Polysorbates
Pharmaceutical Preparations
Powders
Propylene Glycol
Differential Scanning Calorimetry
X-Ray Diffraction
Polymers
Water

Cite this

@article{e3a6c07a81b1482fa532a11f0c40906a,
title = "Effect of solvent on retarding the release of diltiazem HCl from Polyox-based liquisolid tablets",
abstract = "Objectives: The aim of this work was to investigate the use of liquisolid technique to sustain the release of a model highly soluble drug, diltiazem HCl, from liquisolid matrices containing Polyox, a recently proposed matrix-forming hydrophilic polymer as an alternative to hypromellose. Methods: Polyox-based liquisolid formulations prepared using several non-volatile solvents (i.e. polysorbate 80, polyethylene glycol, polyethylene glycol 200 and polyethylene glycol 600) and then characterised using differential scanning calorimetry and powder X-ray diffraction. The influence of solvent on retarding the release of diltiazem HCl from Polyox-based liquisolid tablets compared to conventional physical mixture tablets was studied. Key findings: Liquisolid tablets exhibited greater retarding properties compared to conventional tablets. The use of polysorbate produced a slower release pattern of the drug from diltiazem hydrochloride (DTZ) liquisolid tablets compared to propylene glycol and polyethylene glycol (200 and 600). The release retardation was decreased with the increase in the concentration of the drug within drug:solvent liquid medication used. Solid-state analysis suggested the presence of a fraction of the drug mass in a solubilised state within polysorbate in liquisolid powders. Conclusion: Polyox-based matrix tablets prepared using liquisolid technique in the presence of a carefully selected non-volatile solvent could produce desirable, more sustained release profiles of highly water-soluble drugs compared to conventional physical mixture tablets.",
keywords = "diltiazem HCl, liquisolid tablets, matrix systems, Polyox, polysorbate 80, sustained release",
author = "Waseem Kaialy and Hussaini Bello and Kofi Asare-Addo and Ali Nokhodchi",
note = "No record of this in Eprints. HN 27/10/2017",
year = "2016",
month = "11",
doi = "10.1111/jphp.12643",
language = "English",
volume = "68",
pages = "1396--1402",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
publisher = "Pharmaceutical Press",
number = "11",

}

Effect of solvent on retarding the release of diltiazem HCl from Polyox-based liquisolid tablets. / Kaialy, Waseem; Bello, Hussaini; Asare-Addo, Kofi; Nokhodchi, Ali.

In: Journal of Pharmacy and Pharmacology, Vol. 68, No. 11, 11.2016, p. 1396-1402.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of solvent on retarding the release of diltiazem HCl from Polyox-based liquisolid tablets

AU - Kaialy, Waseem

AU - Bello, Hussaini

AU - Asare-Addo, Kofi

AU - Nokhodchi, Ali

N1 - No record of this in Eprints. HN 27/10/2017

PY - 2016/11

Y1 - 2016/11

N2 - Objectives: The aim of this work was to investigate the use of liquisolid technique to sustain the release of a model highly soluble drug, diltiazem HCl, from liquisolid matrices containing Polyox, a recently proposed matrix-forming hydrophilic polymer as an alternative to hypromellose. Methods: Polyox-based liquisolid formulations prepared using several non-volatile solvents (i.e. polysorbate 80, polyethylene glycol, polyethylene glycol 200 and polyethylene glycol 600) and then characterised using differential scanning calorimetry and powder X-ray diffraction. The influence of solvent on retarding the release of diltiazem HCl from Polyox-based liquisolid tablets compared to conventional physical mixture tablets was studied. Key findings: Liquisolid tablets exhibited greater retarding properties compared to conventional tablets. The use of polysorbate produced a slower release pattern of the drug from diltiazem hydrochloride (DTZ) liquisolid tablets compared to propylene glycol and polyethylene glycol (200 and 600). The release retardation was decreased with the increase in the concentration of the drug within drug:solvent liquid medication used. Solid-state analysis suggested the presence of a fraction of the drug mass in a solubilised state within polysorbate in liquisolid powders. Conclusion: Polyox-based matrix tablets prepared using liquisolid technique in the presence of a carefully selected non-volatile solvent could produce desirable, more sustained release profiles of highly water-soluble drugs compared to conventional physical mixture tablets.

AB - Objectives: The aim of this work was to investigate the use of liquisolid technique to sustain the release of a model highly soluble drug, diltiazem HCl, from liquisolid matrices containing Polyox, a recently proposed matrix-forming hydrophilic polymer as an alternative to hypromellose. Methods: Polyox-based liquisolid formulations prepared using several non-volatile solvents (i.e. polysorbate 80, polyethylene glycol, polyethylene glycol 200 and polyethylene glycol 600) and then characterised using differential scanning calorimetry and powder X-ray diffraction. The influence of solvent on retarding the release of diltiazem HCl from Polyox-based liquisolid tablets compared to conventional physical mixture tablets was studied. Key findings: Liquisolid tablets exhibited greater retarding properties compared to conventional tablets. The use of polysorbate produced a slower release pattern of the drug from diltiazem hydrochloride (DTZ) liquisolid tablets compared to propylene glycol and polyethylene glycol (200 and 600). The release retardation was decreased with the increase in the concentration of the drug within drug:solvent liquid medication used. Solid-state analysis suggested the presence of a fraction of the drug mass in a solubilised state within polysorbate in liquisolid powders. Conclusion: Polyox-based matrix tablets prepared using liquisolid technique in the presence of a carefully selected non-volatile solvent could produce desirable, more sustained release profiles of highly water-soluble drugs compared to conventional physical mixture tablets.

KW - diltiazem HCl

KW - liquisolid tablets

KW - matrix systems

KW - Polyox

KW - polysorbate 80

KW - sustained release

UR - http://www.scopus.com/inward/record.url?scp=84990976907&partnerID=8YFLogxK

U2 - 10.1111/jphp.12643

DO - 10.1111/jphp.12643

M3 - Article

VL - 68

SP - 1396

EP - 1402

JO - Journal of Pharmacy and Pharmacology

T2 - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - 11

ER -